Conatus Pharmaceuticals Inc. (CNAT) declined -6.77% or -0.38 to $5.23. It is near to 756695 shares traded, which is 213.86% compare to the average total volume 353822. The market cap of CNAT is $157.79 million. The year to date change is 11.33%. The 52 week price range is from $3.22 to $7.95. Price of CNAT have changed 12.20% during last week. It have changed 45.71% over last month, 48.81% over last 3 months, 7.88% over last 6 months and 5.45% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 4.40. It is -15.87% below current price. The 200-day Moving Averages for CNAT is 4.65. It is -11.09% below current price. The 52-week High is 7.95. It is 52.01% from the current price. The 52-week Low is 3.22. It is -38.43% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CNAT is 7.51 on 2018-08-15. Short % to float is 5.58%. There are some statistics of CNAT. It is has market cap $157.79 million. The share outstanding is 30.17 million. The average volume is 353822. The revenue is 9.57M. It has 85.18M cash and 12.97M in debt. The percent of top 15 Institution holding is 47.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -65.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -21.55%.